Hillsdale Investment Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,850
| Closed | -$407K | – | 681 |
|
|
2023
Q4 | $407K | Hold |
1,850
| – | – | 0.03% | 335 |
|
|
2023
Q3 | $418K | Buy |
1,850
+50
| +3% | +$11.3K | 0.04% | 310 |
|
|
2023
Q2 | $397K | Buy |
1,800
+50
| +3% | +$11K | 0.04% | 294 |
|
|
2023
Q1 | $392K | Buy |
1,750
+1,700
| +3,400% | +$381K | 0.03% | 381 |
|
|
2022
Q4 | $13.9K | Hold |
50
| – | – | ﹤0.01% | 511 |
|
|
2022
Q3 | $10K | Hold |
50
| – | – | ﹤0.01% | 513 |
|
|
2022
Q2 | $12K | Buy |
+50
| New | +$12K | ﹤0.01% | 490 |
|
|
2021
Q3 | – | Sell |
-65
| Closed | -$12K | – | 643 |
|
|
2021
Q2 | $12K | Sell |
65
-3,600
| -98% | -$665K | ﹤0.01% | 529 |
|
|
2021
Q1 | $613K | Sell |
3,665
-450
| -11% | -$75.3K | 0.05% | 310 |
|
|
2020
Q4 | $625K | Buy |
4,115
+50
| +1% | +$7.59K | 0.06% | 278 |
|
|
2020
Q3 | $411K | Buy |
4,065
+100
| +3% | +$10.1K | 0.04% | 363 |
|
|
2020
Q2 | $480K | Buy |
+3,965
| New | +$480K | 0.04% | 329 |
|
|
2015
Q2 | – | Sell |
-2,100
| Closed | -$362K | – | 565 |
|
|
2015
Q1 | $362K | Buy |
2,100
+500
| +31% | +$86.2K | 0.09% | 206 |
|
|
2014
Q4 | $207K | Sell |
1,600
-100
| -6% | -$12.9K | 0.05% | 325 |
|
|
2014
Q3 | $219K | Buy |
+1,700
| New | +$219K | 0.07% | 293 |
|
|
2014
Q2 | – | Sell |
-100
| Closed | -$9K | – | 596 |
|
|
2014
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 488 |
|
|
2013
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 470 |
|
|
2013
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 475 |
|
|
2013
Q2 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 491 |
|